The National Institutes of Health (NIH) is actually the second-highest funding source for drug studies (first is the drug companies, themselves). Many assume NIH-funded studies are unbiased, but NIH accepts a great deal of money from Big Pharma and is deeply enmeshed with the industry,
The revolving door between government and the pharmaceutical industry had barely stopped spinning from January 2011, when Elias Zerhouni, former director of the NIH — one of the world’s foremost medical research centers, and an agency of the U.S. Department of Health and Human Services — became the president of Sanofi-Aventis’ research labs.
Now another NIH leader – Gary Nabel, one of NIH’s most prominent researchers who heads up the agency’s Vaccine Research Center (VRC) – has announced that he will become chief scientific officer at Sanofi in December 2012…
Join us on our
Share this page with your friends
on your favorite social network: